NO160513C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive aroylimidazoloner. - Google Patents
Analogifremgangsmaate ved fremstilling av terapeutisk aktive aroylimidazoloner.Info
- Publication number
- NO160513C NO160513C NO840535A NO840535A NO160513C NO 160513 C NO160513 C NO 160513C NO 840535 A NO840535 A NO 840535A NO 840535 A NO840535 A NO 840535A NO 160513 C NO160513 C NO 160513C
- Authority
- NO
- Norway
- Prior art keywords
- aroylimidazolons
- preparation
- therapeutically active
- analogy procedure
- analogy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/70—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/84—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US46640983A | 1983-02-15 | 1983-02-15 | |
| US06/562,758 US4552880A (en) | 1983-02-15 | 1983-12-21 | Aroylimidazolones |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO840535L NO840535L (no) | 1984-08-16 |
| NO160513B NO160513B (no) | 1989-01-16 |
| NO160513C true NO160513C (no) | 1989-04-26 |
Family
ID=27041649
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO840535A NO160513C (no) | 1983-02-15 | 1984-02-14 | Analogifremgangsmaate ved fremstilling av terapeutisk aktive aroylimidazoloner. |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US4552880A (da) |
| EP (1) | EP0118790B1 (da) |
| KR (1) | KR900001178B1 (da) |
| AR (1) | AR240811A1 (da) |
| AU (1) | AU562323B2 (da) |
| CA (1) | CA1264325C (da) |
| DE (1) | DE3472556D1 (da) |
| DK (1) | DK160821C (da) |
| ES (1) | ES8505351A1 (da) |
| GR (1) | GR81511B (da) |
| IE (1) | IE57037B1 (da) |
| IL (1) | IL70943A (da) |
| NO (1) | NO160513C (da) |
| NZ (1) | NZ207109A (da) |
| PT (1) | PT78108B (da) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4743612A (en) * | 1986-10-17 | 1988-05-10 | Berlex Laboratories, Inc. | Prodrug derivatives of the cardiotonic agent 4-ethyl-1,3-dihydro-5-(4-(2-methyl-1H-imidazol-1-yl)benzoyl)-2H-imidazol-2-one, composition containing them, and method of using them to treat cardiac failure |
| ZA881807B (en) * | 1987-03-20 | 1988-09-05 | Merrell Dow Pharmaceuticals Inc. | Method for reducing reperfusion injury with imidazol-2-thiones |
| US4999365A (en) * | 1987-03-20 | 1991-03-12 | Merrell Dow Pharmaceuticals Inc. | Method of reducing reperfusion injury with imidazol-2-thiones |
| US20030185882A1 (en) * | 2001-11-06 | 2003-10-02 | Vergez Juan A. | Pharmaceutical compositions containing oxybutynin |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2397250A (en) * | 1944-04-29 | 1946-03-26 | Hoffmann La Roche | Compounds of the imidazolidone series and process of making them |
| PH18106A (en) * | 1981-02-18 | 1985-03-21 | Merrell Dow Pharma | Novel-4-aroylimidazol-2-ones |
| US4405628A (en) * | 1981-03-05 | 1983-09-20 | Merrell Dow Pharmaceuticals Inc. | 4-Pyridylimidazolones and method of use |
| ZA822990B (en) * | 1981-05-04 | 1983-03-30 | Merrell Dow Pharma | 4-oxymethyl-5-acyl-1,3-dihydro-2h-imidazol-2-ones |
-
1983
- 1983-12-21 US US06/562,758 patent/US4552880A/en not_active Expired - Lifetime
-
1984
- 1984-02-10 NZ NZ207109A patent/NZ207109A/en unknown
- 1984-02-13 GR GR73787A patent/GR81511B/el unknown
- 1984-02-13 CA CA447247A patent/CA1264325C/en not_active Expired
- 1984-02-13 IL IL70943A patent/IL70943A/xx unknown
- 1984-02-13 AU AU24541/84A patent/AU562323B2/en not_active Ceased
- 1984-02-14 DK DK065984A patent/DK160821C/da not_active IP Right Cessation
- 1984-02-14 ES ES84529721A patent/ES8505351A1/es not_active Expired
- 1984-02-14 KR KR1019840000691A patent/KR900001178B1/ko not_active IP Right Cessation
- 1984-02-14 DE DE8484101522T patent/DE3472556D1/de not_active Expired
- 1984-02-14 NO NO840535A patent/NO160513C/no unknown
- 1984-02-14 AR AR295710A patent/AR240811A1/es active
- 1984-02-14 EP EP84101522A patent/EP0118790B1/en not_active Expired
- 1984-02-14 IE IE335/84A patent/IE57037B1/en not_active IP Right Cessation
- 1984-02-15 PT PT78108A patent/PT78108B/pt not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| NO160513B (no) | 1989-01-16 |
| IE840335L (en) | 1984-08-15 |
| GR81511B (da) | 1984-12-11 |
| KR900001178B1 (ko) | 1990-02-27 |
| EP0118790A1 (en) | 1984-09-19 |
| IL70943A0 (en) | 1984-05-31 |
| DK65984D0 (da) | 1984-02-14 |
| DK160821C (da) | 1991-10-14 |
| PT78108A (en) | 1984-03-01 |
| NO840535L (no) | 1984-08-16 |
| NZ207109A (en) | 1986-06-11 |
| US4552880A (en) | 1985-11-12 |
| IL70943A (en) | 1988-07-31 |
| AR240811A2 (es) | 1991-02-28 |
| KR840007725A (ko) | 1984-12-10 |
| DE3472556D1 (en) | 1988-08-11 |
| DK160821B (da) | 1991-04-22 |
| ES529721A0 (es) | 1985-05-16 |
| AU562323B2 (en) | 1987-06-04 |
| CA1264325A (en) | 1990-01-09 |
| ES8505351A1 (es) | 1985-05-16 |
| DK65984A (da) | 1984-08-16 |
| EP0118790B1 (en) | 1988-07-06 |
| CA1264325C (en) | 1990-01-09 |
| AU2454184A (en) | 1984-08-23 |
| AR240811A1 (es) | 1991-02-28 |
| IE57037B1 (en) | 1992-03-25 |
| PT78108B (en) | 1986-05-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO163691C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive n-acryl-piperazinalkanamider. | |
| NO160521C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 13alfa- alkylgonaner. | |
| NO158021C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktivt d-fenylalanyl-l-prolyl-l-argininaldehydsulfat. | |
| NO160368C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive bicykliske azoforbindelser. | |
| NO162858C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive thiazolidinderivater. | |
| NO158060C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonforbindelser. | |
| NO161679C (no) | Analogifremgangsm te ved fremstilling av terapeutisk aktive steroider. | |
| NO166083C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyridazodiazepinderivater. | |
| NO165841C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive heteroaryl-3-okso-propannitril-derivater. | |
| NO158534C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenoksyalkylkarboksylsyrederivater. | |
| NO159930C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive indeno-pyridazinon-derivater. | |
| NO153370C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive, stabile s-adenosylmethionisalter. | |
| NO165400C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive cefemforbindelser. | |
| NO159528C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive aminoguanidinderivater. | |
| NO165842C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-forbindelser. | |
| NO157538C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzothiazolsufonamidderivater. | |
| NO164020C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenetanolaminderivater. | |
| NO158673C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive azurenderivater. | |
| NO161313C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorallylaminderivater. | |
| NO164416C (no) | Analogiremgangsmaate ved fremstilling av terapeutisk aktive 5-acyl-2-(1h)-pyridinoner. | |
| NO163330C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive isokinolinderivater. | |
| NO158376C (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme rooperolforbindelser. | |
| NO157934C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive antracyklinglykosider. | |
| NO154494C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorprostacykliner. | |
| NO163896C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive spiro-(1,8)-nafthyridin-dioner. |